AAU and SAJA Pharmaceuticals raise awareness at Khorfakkan Hospital

AAU and SAJA Pharmaceuticals raise awareness at Khorfakkan Hospital

Dubai: The Arab Association of Urology (AAU) and its educational platform, the Arab School of Urology (ASU) collaborated with the Saudi-based SAJA Pharmaceuticals for a public awareness program about overactive bladder (OAB) and urinary Incontinence at Khorfakkan Hospital. This was the first of many collaborations to promote preventable urological health issues by the AAU and SAJA Pharmaceuticals following their signing of a memorandum of understanding (MoU) the previous week.

The scientific program aimed to educate and raise awareness about the common urological conditions and discussed various important and relevant topics including their effects, how they worsen with age, methods for diagnosis, and possible treatments.

Dr Yasser Farahat, Secretary General of the AAU said, “It is very important to be aware and prepared for a condition like OAB as it is extremely bothersome. It affects over 400 million people worldwide and is common in both men and women. It can cause considerable stress, depression, insomnia, anxiety, sexual & social problems, and just generally has a negative impact on the patient’s quality of life.”

“Many risk factors might aggravate OAB symptoms like advancing age, being overweight, urinary tract infections, low oestrogen levels after menopause, nervous system diseases, Diabetes, benign prostatic hyperplasia (BPH), prior pelvic surgery,